These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28384640)

  • 1. Comparative Diagnostic Accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for Screening of Alzheimer Disease.
    Matías-Guiu JA; Valles-Salgado M; Rognoni T; Hamre-Gil F; Moreno-Ramos T; Matías-Guiu J
    Dement Geriatr Cogn Disord; 2017; 43(5-6):237-246. PubMed ID: 28384640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Diagnostic Accuracy of Five Cognitive Screening Tests for Diagnosing Mild Cognitive Impairment in Patients Consulting for Memory Loss.
    Valles-Salgado M; Matias-Guiu JA; Delgado-Álvarez A; Delgado-Alonso C; Gil-Moreno MJ; Valiente-Gordillo E; López-Carbonero JI; Fernández-Romero L; Peña-DeDiego L; Oliver-Mas S; Matías-Guiu J; Diez-Cirarda M
    J Clin Med; 2024 Aug; 13(16):. PubMed ID: 39200837
    [No Abstract]   [Full Text] [Related]  

  • 3. Performance of three cognitive screening tools in a sample of older New Zealanders.
    Cheung G; Clugston A; Croucher M; Malone D; Mau E; Sims A; Gee S
    Int Psychogeriatr; 2015 Jun; 27(6):981-9. PubMed ID: 25603424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
    Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
    Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation Study of the Chinese Version of Addenbrooke's Cognitive Examination III for Diagnosing Mild Cognitive Impairment and Mild Dementia.
    Li X; Yang L; Yin J; Yu N; Ye F
    J Clin Neurol; 2019 Jul; 15(3):313-320. PubMed ID: 31286702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of the accuracy of the Addenbrooke's Cognitive Examination (ACE) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) in the detection of dementia.
    Larner AJ; Mitchell AJ
    Int Psychogeriatr; 2014 Apr; 26(4):555-63. PubMed ID: 24423470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion between Addenbrooke's Cognitive Examination III and Mini-Mental State Examination.
    Matías-Guiu JA; Pytel V; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2018 Aug; 30(8):1227-1233. PubMed ID: 29223183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment.
    Pan FF; Wang Y; Huang L; Huang Y; Guo QH
    Aging Ment Health; 2022 Feb; 26(2):384-391. PubMed ID: 33533261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Validation Study of the Chinese Version of the Mini-Addenbrooke's Cognitive Examination for Screening Mild Cognitive Impairment and Mild Dementia.
    Yang L; Li X; Yin J; Yu N; Liu J; Ye F
    J Geriatr Psychiatry Neurol; 2019 Jul; 32(4):205-210. PubMed ID: 30987514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Rowland Universal Dementia Assessment Scale for multicultural screening in Danish memory clinics.
    Nielsen TR; Andersen BB; Gottrup H; Lützhøft JH; Høgh P; Waldemar G
    Dement Geriatr Cogn Disord; 2013; 36(5-6):354-62. PubMed ID: 24022429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment.
    Ridley N; Batchelor J; Draper B; Demirkol A; Lintzeris N; Withall A
    J Clin Exp Neuropsychol; 2018 Mar; 40(2):107-122. PubMed ID: 28436744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing dementia in lower educated older persons: validation of a Brazilian Portuguese version of the Rowland Universal Dementia Assessment Scale (RUDAS).
    de Araujo NB; Nielsen TR; Engedal K; Barca ML; Coutinho ES; Laks J
    Braz J Psychiatry; 2018; 40(3):264-269. PubMed ID: 29451587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing.
    Lam B; Middleton LE; Masellis M; Stuss DT; Harry RD; Kiss A; Black SE
    J Am Geriatr Soc; 2013 Dec; 61(12):2181-2185. PubMed ID: 24320735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening.
    Horton DK; Hynan LS; Lacritz LH; Rossetti HC; Weiner MF; Cullum CM
    Clin Neuropsychol; 2015; 29(4):413-25. PubMed ID: 25978540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Rowland Universal Dementia Assessment Scale (RUDAS) in a multicultural sample across five Western European countries: diagnostic accuracy and normative data.
    Nielsen TR; Segers K; Vanderaspoilden V; Bekkhus-Wetterberg P; Bjørkløf GH; Beinhoff U; Minthon L; Pissiota A; Tsolaki M; Gkioka M; Waldemar G
    Int Psychogeriatr; 2019 Feb; 31(2):287-296. PubMed ID: 30017010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan.
    Wang CS; Pai MC; Chen PL; Hou NT; Chien PF; Huang YC
    Int Psychogeriatr; 2013 Nov; 25(11):1839-48. PubMed ID: 23919950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Chinese version of Addenbrooke's Cognitive Examination III for diagnosing dementia.
    Wang BR; Ou Z; Gu XH; Wei CS; Xu J; Shi JQ
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):e173-e179. PubMed ID: 28170114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Korean Addenbrooke's Cognitive Examination for diagnosing Alzheimer's dementia and mild cognitive impairment in the Korean elderly.
    Heo JH; Lee KM; Park TH; Ahn JY; Kim MK
    Appl Neuropsychol Adult; 2012; 19(2):127-31. PubMed ID: 23373580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.